Related Experiment Video
Updated: Aug 18, 2026
05:30
Clonogenic Assay: Adherent Cells
Published on: March 13, 2011
Alpha-fetoprotein assay in patients treated with low-dose oral contraceptives
Clinical and Experimental Obstetrics & Gynecology
|January 1, 1984
Abstract:
AFP has proven to be a useful marker for liver neoplasms. The authors assayed AFP plasma levels in patients taking low-dose estro- progestinics . Patients were divided into three groups on the basis of their living habits. No difference was found in any group between AFP levels before and after treatment. However, in the group of smokers using oral contraceptives AFP levels were significantly higher.
Keywords:
Alcohol DrinkingBehaviorBiologyContraceptionContraceptive Agents, Female--side effectsContraceptive Agents--side effectsContraceptive Methods--side effectsDeveloped CountriesDiseasesEuropeFamily PlanningHepatic EffectsItalyLiver NeoplasmsMediterranean CountriesNeoplasmsOral Contraceptives, Low-dose--side effectsOral Contraceptives--side effectsPhysiologySmokingSocial BehaviorSouthern Europe
